Table 1.
Baseline characteristics of Laboratory findings of patients with COVID-19.
| Characteristic | Normal Range |
Mild cases (n = 32) |
Moderate cases (n = 23) |
Severe cases (n = 9) |
P-value |
|---|---|---|---|---|---|
| M/F | M15/F17 | M13/F10 | M8/F1 | ||
| AGE | 54 (33–73) | 57 (21–83) | 61 (47–81) | 0.0736 | |
| GLU | 3.9–6.1 mmol/L | 6.2 (5.71–6.7) | 8.45 (7.09–9.82) | 9.78 (5.61–13.96) | <0.0001 |
| LDL | 1.07–3.3 mmol/L | 2.30 (2.03–2.58) | 2.29 (2.01–2.57) | 1.52 (1.19–1.85) | 0.0094 |
| D-Dimer | 0–0.55 mg/L | 0.65 (0.42–0.87) | 1.91 (0.3–3.51) | 22.79 (−4.14–49.72) | 0.0002 |
| NLR | 4.58 (2.64–6.52) | 5.14 (3.6–6.69) | 16.05 (6.39–25.72) | <0.0001 | |
| CRP | 0–6 mg/L | 38.05 (18.5–57.59) | 58.72 (33.08–84.37) | 147.87 (95.95–199.8) | <0.0001 |
| PCT | <0.50 ng/mL | 0.18 (0.12–0.23) | 0.14 (0.12–0.17) | 5.99 (−6.6–18.58) | 0.0385 |
| IL-6 | <7 pg/mL | 12.3 (2.20–22.39) | 18.87 (8.27–29.39) | 55.49 (−28–139) | 0.0197 |
| LY# | (1.1–3.2) * 109/L | 1.34 (1.14–1.55) | 1.12 (0.86–1.38) | 0.64 (0.33–0.96) | 0.0056 |
| MCH | 27–34 pg | 31.43 (30.71–32.15) | 30.41 (29.36–31.46) | 30.89 (29.21–32.57) | 0.2394 |
| MCHC | 316–354 g/L | 351.25 (345.6–356.9) | 350.91 (342.6–359.2) | 346.44 (337.5–355.4) | 0.3088 |
| MCV | 82–100 fL | 89.53 (87.91–91.14) | 86.69 (84.52–88.86) | 89.23 (83.89–94.58) | 0.117 |
| MPV | 5.0–11.0 fL | 9.525 (8.94–10.11) | 9.38 (8.76–10) | 9.54 (8.2–10.88) | 0.9342 |
| NEUT# | (1.8–6.3) * 109/L | 4.96 (3.22–6.69) | 4.29 (3.61–4.96) | 8.16 (4.8–11.52) | 0.0438 |
| PLT | (125–350) * 109/L | 247.16 (212.9–281.4) | 269.13 (225–313.2) | 172.11 (105.8–238.4) | 0.0439 |
| RDW-CV | 11–15% | 12.72 (12.5–12.94) | 12.81 (12.5–13.12) | 13.12 (12.2–14.04) | 0.3739 |
| RDW-SD | 37–54% | 40.93 (40.04–41.83) | 39.83 (38.84–40.83) | 41.82 (38.78–44.87) | 0.1277 |
| RET# | (0.024–0.084) * 1012/L | 0.04 (0.029–0.045) | 0.034 (0.027–0.04) | 0.028 (0.019–0.036) | 0.4071 |
| WBC | (3.5–9.5) * 109/L | 6.92 (5.18–8.67) | 5.89 (5.08–6.7) | 9.17 (5.64–12.69) | 0.1213 |
| A/G | 1.2–2.4 | 1.5 (1.36–1.64) | 1.44 (1.24–1.64) | 1.27 (1.01–1.52) | 0.3197 |
| AG | 8–16 mmol/L | 13.06 (11.71–14.4) | 13.2 (11.41–14.98) | 15.32 (11.07–19.57) | 0.3285 |
| ALB | 40–55 g/L | 39.13 (37.85–40.42) | 37.12 (35.5–38.74) | 33.54 (30.09–37) | 0.0008 |
| ALP | 45–125 U/L | 44.75 (38.69–50.81) | 45.13 (39.07–51.19) | 64.56 (44.17–84.94) | 0.0109 |
| ALT | 9–60 U/L | 26.25 (17.66–34.84) | 35.65 (16.68–54.62) | 281 (−320.9–882.9) | 0.0574 |
| APOA | 0.9–1.6 g/L | 0.93 (0.86–1.01) | 0.76 (0.7–0.82) | 0.61 (0.56–0.66) | <0.0001 |
| APOB | 0.6–1.1 g/L | 0.78 (0.7–0.86) | 0.76 (0.67–0.86) | 0.55 (0.43–0.66) | 0.017 |
| AST | 15–45 U/L | 27.19 (22.01–32.36) | 42.57 (22.88–62.25) | 753.1 (−898.3–2405) | 0.0434 |
| CA2+ | 2.11–2.52 mmol/L | 2.14 (2.1–2.18) | 2.13 (2.06–2.2) | 1.94 (1.86–2.02) | 0.0005 |
| LDH | 125–250 U/L | 286.97 (237.5–336.5) | 322.96 (239.7–406.2) | 1,040.56 (84.01–1997) | 0.0004 |
| sdLDL | 0.27–1.44 mmol/L | 0.80 (0.69–0.90) | 0.75 (0.64–0.85) | 0.39 (0.27–0.51) | 0.0004 |
#
Absolute number.